Myostatin: A Powerful Biomarker for Sarcopenia and Frailty?
- PMID: 30870838
- DOI: 10.1159/000495839
Myostatin: A Powerful Biomarker for Sarcopenia and Frailty?
Comment in
-
Myostatin as a Biomarker for Diagnosis or Prognosis of Frailty and Sarcopenia: Current Knowledge.Gerontology. 2019;65(4):385-386. doi: 10.1159/000496469. Epub 2019 Mar 1. Gerontology. 2019. PMID: 30820018 No abstract available.
Comment on
-
Serum Myostatin Levels Are Higher in Fitter, More Active, and Non-Frail Long-Term Nursing Home Residents and Increase after a Physical Exercise Intervention.Gerontology. 2019;65(3):229-239. doi: 10.1159/000494137. Epub 2018 Nov 21. Gerontology. 2019. PMID: 30463070 Clinical Trial.
Similar articles
-
Myostatin as a Biomarker for Diagnosis or Prognosis of Frailty and Sarcopenia: Current Knowledge.Gerontology. 2019;65(4):385-386. doi: 10.1159/000496469. Epub 2019 Mar 1. Gerontology. 2019. PMID: 30820018 No abstract available.
-
Serum Myostatin Levels Are Higher in Fitter, More Active, and Non-Frail Long-Term Nursing Home Residents and Increase after a Physical Exercise Intervention.Gerontology. 2019;65(3):229-239. doi: 10.1159/000494137. Epub 2018 Nov 21. Gerontology. 2019. PMID: 30463070 Clinical Trial.
-
Sarcopenia and Frailty in Heart Failure: Is There a Biomarker Signature?Curr Heart Fail Rep. 2022 Dec;19(6):400-411. doi: 10.1007/s11897-022-00575-w. Epub 2022 Oct 20. Curr Heart Fail Rep. 2022. PMID: 36261756 Free PMC article. Review.
-
Inflammatory biomarkers and frailty among older hospitalized patients: author's response.Aging Clin Exp Res. 2019 Aug;31(8):1179-1180. doi: 10.1007/s40520-019-01198-3. Epub 2019 Apr 17. Aging Clin Exp Res. 2019. PMID: 30997662 No abstract available.
-
Frailty and sarcopenia as the basis for the phenotypic manifestation of chronic diseases in older adults.Mol Aspects Med. 2016 Aug;50:1-32. doi: 10.1016/j.mam.2016.06.001. Epub 2016 Jun 28. Mol Aspects Med. 2016. PMID: 27370407 Review.
Cited by
-
Effects of Twelve Weeks of Square Stepping Exercises on Physical and Cognitive Function and Plasma Content of SMP30: A Randomised Control Trial.Geriatrics (Basel). 2025 Feb 7;10(1):22. doi: 10.3390/geriatrics10010022. Geriatrics (Basel). 2025. PMID: 39997521 Free PMC article.
-
A Prospective Case-Control Study Examining the Relationship Between Frailty and Serum Myostatin in Older Persons with Chronic Heart Failure.Risk Manag Healthc Policy. 2023 Jul 20;16:1343-1349. doi: 10.2147/RMHP.S412725. eCollection 2023. Risk Manag Healthc Policy. 2023. PMID: 37497257 Free PMC article.
-
Prevalence of Sarcopenic Obesity in Various Comorbidities, Diagnostic Markers, and Therapeutic Approaches: A Review.Ann Geriatr Med Res. 2022 Dec;26(4):296-308. doi: 10.4235/agmr.22.0081. Epub 2022 Nov 18. Ann Geriatr Med Res. 2022. PMID: 36397294 Free PMC article.
-
A Multifactorial Approach for Sarcopenia Assessment: A Literature Review.Biology (Basel). 2021 Dec 20;10(12):1354. doi: 10.3390/biology10121354. Biology (Basel). 2021. PMID: 34943268 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources